{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:31:29Z","timestamp":1786995089849,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["43014982"],"award-info":[{"award-number":["43014982"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["2R15HL143545-02"],"award-info":[{"award-number":["2R15HL143545-02"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nmni.2025.101623","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T01:23:07Z","timestamp":1755825787000},"page":"101623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anti-TB treatment outcomes in TB meningitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"given":"Samin","family":"Afazel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3279-0671","authenticated-orcid":false,"given":"Mohammad J.","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.nmni.2025.101623_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000069","article-title":"The global burden of tuberculous meningitis in adults: a modelling study","volume":"1","author":"Dodd","year":"2021","journal-title":"PLOS Glob Publ Health"},{"issue":"2","key":"10.1016\/j.nmni.2025.101623_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279203","article-title":"Microbiological diagnosis and mortality of tuberculosis meningitis: systematic review and meta-analysis","volume":"18","author":"Seid","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.nmni.2025.101623_bib3","series-title":"Global tuberculosis report 2024","author":"Organization","year":"2024"},{"issue":"1","key":"10.1016\/j.nmni.2025.101623_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Salari","year":"2023","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"10.1016\/j.nmni.2025.101623_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QCO.0000000000000648","article-title":"Tuberculous meningitis: where to from here?","volume":"33","author":"Donovan","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.nmni.2025.101623_bib6","series-title":"WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents","author":"Organization","year":"2022"},{"key":"10.1016\/j.nmni.2025.101623_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-018-0490-9","article-title":"Treatment of tuberculous meningitis and its complications in adults","volume":"20","author":"Davis","year":"2018","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.nmni.2025.101623_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2022.834013","article-title":"Treatment of tuberculosis and the drug interactions associated with HIV-TB co-infection treatment","volume":"3","author":"Pooranagangadevi","year":"2022","journal-title":"Front Trop Dis"},{"issue":"1","key":"10.1016\/j.nmni.2025.101623_bib9","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1186\/s12889-024-19683-4","article-title":"Prevalence, incidence, and case fatality of tuberculous meningitis in adults living with HIV: a systematic review and meta-analysis","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.nmni.2025.101623_bib10","series-title":"PRISMA 2020","first-page":"A5","author":"Tugwell","year":"2021"},{"key":"10.1016\/j.nmni.2025.101623_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.12688\/f1000research.24469.2","article-title":"The use of \u2018PICO for synthesis\u2019 and methods for synthesis without meta-analysis: protocol for a survey of current practice in systematic reviews of health interventions","volume":"9","author":"Cumpston","year":"2021","journal-title":"F1000Research"},{"issue":"11","key":"10.1016\/j.nmni.2025.101623_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","article-title":"Tuberculous meningitis: a uniform case definition for use in clinical research","volume":"10","author":"Marais","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2025.101623_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1064642","article-title":"Reliability of the modified Rankin Scale in clinical practice of stroke units and rehabilitation wards","volume":"14","author":"Po\u017carowszczyk","year":"2023","journal-title":"Front Neurol"},{"issue":"11","key":"10.1016\/j.nmni.2025.101623_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106088","article-title":"Predictors of infarction in tuberculous meningitis in Indian patients","volume":"30","author":"Bhasin","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.nmni.2025.101623_bib15","series-title":"Cochrane handbook for systematic reviews of diagnostic test accuracy","author":"Deeks","year":"2023"},{"key":"10.1016\/j.nmni.2025.101623_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/9781119099369.ch27","article-title":"Comprehensive meta\u2010analysis software","author":"Borenstein","year":"2022","journal-title":"Syst Rev Health Res: Meta-anal Context"},{"issue":"2","key":"10.1016\/j.nmni.2025.101623_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed\u2010effect and random\u2010effects models for meta\u2010analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.nmni.2025.101623_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1435","article-title":"Meta-analyses: what is heterogeneity?","volume":"350","author":"Sedgwick","year":"2015","journal-title":"Bmj"},{"key":"10.1016\/j.nmni.2025.101623_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s11606-018-4425-7","article-title":"Empirical comparison of publication bias tests in meta-analysis","volume":"33","author":"Lin","year":"2018","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.nmni.2025.101623_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102351","article-title":"Escalate: linezolid as an add on treatment in the intensive phase of tubercular meningitis. A randomized controlled pilot trial","volume":"142","author":"Sahib","year":"2023","journal-title":"Tuberculosis"},{"issue":"8","key":"10.1016\/j.nmni.2025.101623_bib21","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/cid\/ciac932","article-title":"A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus\u2013associated tuberculous meningitis: the LASER-TBM trial","volume":"76","author":"Davis","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.nmni.2025.101623_bib22","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/cid\/ciac208","article-title":"Randomized clinical trial of high-dose rifampicin with or without levofloxacin versus standard of care for pediatric tuberculous meningitis: the TBM-KIDS trial","volume":"75","author":"Paradkar","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.nmni.2025.101623_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/cid\/ciab162","article-title":"High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly human immunodeficiency virus (HIV)-positive Ugandan adults: a phase II open-label randomized controlled trial","volume":"73","author":"Cresswell","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2025.101623_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/trstmh\/traa144","article-title":"Standard versus sequential anti-tubercular treatment in patients with tuberculous meningitis: a randomized controlled trial","volume":"115","author":"Misra","year":"2021","journal-title":"Trans Roy Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.nmni.2025.101623_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jiy588","article-title":"Pretreatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment","volume":"219","author":"Thuong","year":"2019","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.nmni.2025.101623_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1507062","article-title":"Intensified antituberculosis therapy in adults with tuberculous meningitis","volume":"374","author":"Heemskerk","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmni.2025.101623_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2016.01.004","article-title":"Safety and efficacy of additional levofloxacin in tuberculous meningitis: a randomized controlled pilot study","volume":"98","author":"Kalita","year":"2016","journal-title":"Tuberculosis"},{"issue":"8","key":"10.1016\/j.nmni.2025.101623_bib28","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/jac\/dku103","article-title":"Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial","volume":"69","author":"Kalita","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.nmni.2025.101623_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2025.101623_bib30","series-title":"Open forum infectious diseases","article-title":"Treatment outcomes in adult tuberculous meningitis: a systematic review and meta-analysis","author":"Stadelman","year":"2020"},{"key":"10.1016\/j.nmni.2025.101623_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-019-0966-8","article-title":"Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.nmni.2025.101623_bib32","article-title":"Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: an updated systematic review and meta-analysis","volume":"34","author":"Rehman","year":"2024","journal-title":"J Clin Tuberculosis Mycobacterial Dis"},{"key":"10.1016\/j.nmni.2025.101623_bib33","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.ijid.2022.02.043","article-title":"Delamanid-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"124","author":"Nasiri","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.nmni.2025.101623_bib34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/vaccines12121397","article-title":"Challenges of multidrug-resistant tuberculosis meningitis: current treatments and the role of glutathione as an adjunct therapy","volume":"12","author":"Nasiri","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.nmni.2025.101623_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.657775","article-title":"Effects of oral liposomal glutathione in altering the immune responses against mycobacterium tuberculosis and the mycobacterium bovis bcg strain in individuals with type 2 diabetes","volume":"11","author":"To","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2025.101623_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1515\/bmc-2021-0003","article-title":"The effects of oral liposomal glutathione and in vitro everolimus in altering the immune responses against Mycobacterium bovis BCG strain in individuals with type 2 diabetes","volume":"12","author":"To","year":"2021","journal-title":"Biomol Concepts"},{"issue":"5","key":"10.1016\/j.nmni.2025.101623_bib37","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/biomedicines11051340","article-title":"Glutathione modulates efficacious changes in the immune response against tuberculosis","volume":"11","author":"Abnousian","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.nmni.2025.101623_bib38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/JCM.01834-13","article-title":"Evaluation of GeneXpert MTB\/RIF for diagnosis of tuberculous meningitis","volume":"52","author":"Nhu","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2025.101623_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55112-y","article-title":"Low diagnostic accuracy of Xpert MTB\/RIF assay for extrapulmonary tuberculosis: a multicenter surveillance","volume":"9","author":"Allahyartorkaman","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.nmni.2025.101623_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01113-18","article-title":"A systematic review and meta-analysis of the diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis","volume":"57","author":"Pormohammad","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.nmni.2025.101623_bib41","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/cid\/ciaa473","article-title":"Xpert MTB\/RIF ultra for the diagnosis of tuberculous meningitis: a small step forward","volume":"71","author":"Donovan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.nmni.2025.101623_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241974","article-title":"Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis","volume":"15","author":"Dian","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nmni.2025.101623_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/tmi.13525","article-title":"Diagnostic accuracy of Xpert MTB\/RIF for tuberculous meningitis: systematic review and meta\u2010analysis","volume":"26","author":"Hernandez","year":"2021","journal-title":"Trop Med Int Health"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297525000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297525000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:58:33Z","timestamp":1772895513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297525000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"alternative-id":["S2052297525000629"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2025.101623","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TB treatment outcomes in TB meningitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2025.101623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101623"}}